TABLE 9–3.
Strategies for Perimenstrual Migraine Prophylaxis
Class | Specifics |
---|---|
| |
Nonsteroidal anti-inflammatory drugs | Naproxen 550 mg 2 times a day for 5–6 days, ideally starting 1 day before expected headache onset81 |
Mefenamic acid up to 500 mg 3 times a day from the start of headache through menses82 | |
The cyclooxygenase-2 (COX-2) inhibitor celecoxib has shown promise83 in pilot studies | |
Triptans 81 | Frovatriptan 2.5 mg 2 times a day for up to 6 days, ideally beginning 1 day before expected headache onset |
Naratriptan 1 mg 2 times a day for 5–6 days, ideally beginning 1 day before expected headache onset | |
Zolmitriptan 2.5 mg 2 to 3 times a day for up to 7 days, ideally beginning 1 day before expected headache onset | |
Magnesium 81 | Specific formulation studied is not available in the United States, but it is reasonable to use available forms perimenstrually; can also help with perimenstrual syndrome |
Vitamin E | 400 IU/d for 5 days beginning 2 days before menses84 |
Estrogen | Supplementation (“add back”) via patch or gel in teenagers who have migraine without aura83 |